Biochem/physiol Actions
Blocks L-type voltage-dependent calcium channels; antihypertensive.
Features and Benefits
This compound was developed by EKR Therapeutics. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This product has met the following criteria: